Review



hace2 protein cpass sars-cov-2 surrogate virus neutralization test kit  (GenScript corporation)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    GenScript corporation hace2 protein cpass sars-cov-2 surrogate virus neutralization test kit
    Neutralization assay of the hyperimmune sera obtained 30 days post-immunization of BALB/c mice with RBD-P and RBD orally ( A ) and intramuscularly ( B ). The y-axis corresponds to the observed percentage of the inhibition of HRP-conjugated RBD interaction with <t>hACE2.</t> Dashed lines represent manufacturers’ cutoff values (30%). The neutralization assay was performed in duplicate for each mouse serum, and per group. C+ is the positive control. Each boxplot presents the mean as an X, the median as the middle line, the interquartile range as box limits, and the 2.5th and 97.5th percentiles as the whiskers. For all variables with the same letter, the difference between the means is not statistically significant. If two variables have different letters, they are significantly different (p < 0.05). When there are two letters in a data set, this is not significantly different from the data sets with those letters
    Hace2 Protein Cpass Sars Cov 2 Surrogate Virus Neutralization Test Kit, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hace2+protein+cpass+sars-cov-2+surrogate+virus+neutralization+test+kit/hace2+protein/pmc10848483-175-12-25
    Average 90 stars, based on 1 article reviews
    hace2 protein cpass sars-cov-2 surrogate virus neutralization test kit - by Bioz Stars, 2026-10
    90/100 stars

    Images

    1) Product Images from "Oral administration of a recombinant modified RBD antigen of SARS-CoV-2 as a possible immunostimulant for the care of COVID-19"

    Article Title: Oral administration of a recombinant modified RBD antigen of SARS-CoV-2 as a possible immunostimulant for the care of COVID-19

    Journal: Microbial Cell Factories

    doi: 10.1186/s12934-024-02320-5

    Neutralization assay of the hyperimmune sera obtained 30 days post-immunization of BALB/c mice with RBD-P and RBD orally ( A ) and intramuscularly ( B ). The y-axis corresponds to the observed percentage of the inhibition of HRP-conjugated RBD interaction with hACE2. Dashed lines represent manufacturers’ cutoff values (30%). The neutralization assay was performed in duplicate for each mouse serum, and per group. C+ is the positive control. Each boxplot presents the mean as an X, the median as the middle line, the interquartile range as box limits, and the 2.5th and 97.5th percentiles as the whiskers. For all variables with the same letter, the difference between the means is not statistically significant. If two variables have different letters, they are significantly different (p < 0.05). When there are two letters in a data set, this is not significantly different from the data sets with those letters
    Figure Legend Snippet: Neutralization assay of the hyperimmune sera obtained 30 days post-immunization of BALB/c mice with RBD-P and RBD orally ( A ) and intramuscularly ( B ). The y-axis corresponds to the observed percentage of the inhibition of HRP-conjugated RBD interaction with hACE2. Dashed lines represent manufacturers’ cutoff values (30%). The neutralization assay was performed in duplicate for each mouse serum, and per group. C+ is the positive control. Each boxplot presents the mean as an X, the median as the middle line, the interquartile range as box limits, and the 2.5th and 97.5th percentiles as the whiskers. For all variables with the same letter, the difference between the means is not statistically significant. If two variables have different letters, they are significantly different (p < 0.05). When there are two letters in a data set, this is not significantly different from the data sets with those letters

    Techniques Used: Neutralization, Inhibition, Positive Control

    Related Articles

    Virus:

    Article Title: Oral administration of a recombinant modified RBD antigen of SARS-CoV-2 as a possible immunostimulant for the care of COVID-19
    Article Snippet: Ten microliters of mouse serum diluted with sample dilution buffer were incubated for 30 min at 37 °C with HRP-conjugated RBD protein produced in human cells, as indicated by the supplier (Catalog Z03594, Genscript, Ryswick, The Netherlands). .. 100 μL of the sample were placed on a capture plate with hACE2 protein from the cPass SARS-CoV-2 Surrogate virus neutralization test kit (Catalog L00847-A, Genscript, Ryswick, The Netherlands) for 15 min at 37 °C. ..

    Neutralization:

    Article Title: Oral administration of a recombinant modified RBD antigen of SARS-CoV-2 as a possible immunostimulant for the care of COVID-19
    Article Snippet: Ten microliters of mouse serum diluted with sample dilution buffer were incubated for 30 min at 37 °C with HRP-conjugated RBD protein produced in human cells, as indicated by the supplier (Catalog Z03594, Genscript, Ryswick, The Netherlands). .. 100 μL of the sample were placed on a capture plate with hACE2 protein from the cPass SARS-CoV-2 Surrogate virus neutralization test kit (Catalog L00847-A, Genscript, Ryswick, The Netherlands) for 15 min at 37 °C. ..



    Similar Products

    hace2 protein cpass sars-cov-2 surrogate virus neutralization test kit  (GenScript corporation)
    90
    GenScript corporation hace2 protein cpass sars-cov-2 surrogate virus neutralization test kit
    Neutralization assay of the hyperimmune sera obtained 30 days post-immunization of BALB/c mice with RBD-P and RBD orally ( A ) and intramuscularly ( B ). The y-axis corresponds to the observed percentage of the inhibition of HRP-conjugated RBD interaction with <t>hACE2.</t> Dashed lines represent manufacturers’ cutoff values (30%). The neutralization assay was performed in duplicate for each mouse serum, and per group. C+ is the positive control. Each boxplot presents the mean as an X, the median as the middle line, the interquartile range as box limits, and the 2.5th and 97.5th percentiles as the whiskers. For all variables with the same letter, the difference between the means is not statistically significant. If two variables have different letters, they are significantly different (p < 0.05). When there are two letters in a data set, this is not significantly different from the data sets with those letters
    Hace2 Protein Cpass Sars Cov 2 Surrogate Virus Neutralization Test Kit, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hace2+protein+cpass+sars-cov-2+surrogate+virus+neutralization+test+kit/hace2+protein/pmc10848483-175-12-25
    Average 90 stars, based on 1 article reviews
    hace2 protein cpass sars-cov-2 surrogate virus neutralization test kit - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Neutralization assay of the hyperimmune sera obtained 30 days post-immunization of BALB/c mice with RBD-P and RBD orally ( A ) and intramuscularly ( B ). The y-axis corresponds to the observed percentage of the inhibition of HRP-conjugated RBD interaction with hACE2. Dashed lines represent manufacturers’ cutoff values (30%). The neutralization assay was performed in duplicate for each mouse serum, and per group. C+ is the positive control. Each boxplot presents the mean as an X, the median as the middle line, the interquartile range as box limits, and the 2.5th and 97.5th percentiles as the whiskers. For all variables with the same letter, the difference between the means is not statistically significant. If two variables have different letters, they are significantly different (p < 0.05). When there are two letters in a data set, this is not significantly different from the data sets with those letters

    Journal: Microbial Cell Factories

    Article Title: Oral administration of a recombinant modified RBD antigen of SARS-CoV-2 as a possible immunostimulant for the care of COVID-19

    doi: 10.1186/s12934-024-02320-5

    Figure Lengend Snippet: Neutralization assay of the hyperimmune sera obtained 30 days post-immunization of BALB/c mice with RBD-P and RBD orally ( A ) and intramuscularly ( B ). The y-axis corresponds to the observed percentage of the inhibition of HRP-conjugated RBD interaction with hACE2. Dashed lines represent manufacturers’ cutoff values (30%). The neutralization assay was performed in duplicate for each mouse serum, and per group. C+ is the positive control. Each boxplot presents the mean as an X, the median as the middle line, the interquartile range as box limits, and the 2.5th and 97.5th percentiles as the whiskers. For all variables with the same letter, the difference between the means is not statistically significant. If two variables have different letters, they are significantly different (p < 0.05). When there are two letters in a data set, this is not significantly different from the data sets with those letters

    Article Snippet: 100 μL of the sample were placed on a capture plate with hACE2 protein from the cPass SARS-CoV-2 Surrogate virus neutralization test kit (Catalog L00847-A, Genscript, Ryswick, The Netherlands) for 15 min at 37 °C.

    Techniques: Neutralization, Inhibition, Positive Control